We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Dried Blood Spots Detect Clonal B-Cell Populations

By LabMedica International staff writers
Posted on 14 Oct 2013
The reliability of lymphoma diagnoses is strikingly different between developed and developing countries due to lack of access to advanced techniques.

Molecular methods are important tools for diagnosis and monitoring of many lymphoproliferative disorders, and new application of dried blood spots (DBS) for detecting clonal B-cell populations in peripheral blood (PB) has been proposed. More...


Scientists at the University of Padua (Italy) obtained blood samples from six patients with B-cell chronic lymphocytic leukemia (B-CLL) and five consenting healthy volunteer donors. Dried blood spot samples from African children with non-Hodgkin's lymphoma (NHL) were also analyzed.

Genomic DNA was isolated with the automated MagNA Pure Compact instrument (Roche Applied Science, Indianapolis, IN, USA) The extracted DNA samples were tested for B-cell immunoglobulin heavy chain (IGH) clonality with the IGH gene clonality assay (Invivoscribe Technologies; San Diego, CA, USA), containing BIOMED-2 primers, positive and negative controls.

The Namalwa B-cell line was used to establish that the assay was sensitive enough to detect 200 clonal cells in the analyzed sample. Very similar clonal results were obtained between DNA from DBS and fresh whole blood from patients with B-cell chronic lymphocytic leukemia. B-cell clonality can also be detected in DBS from African children with Epstein-Barr Virus (EBV)-associated diseases.

DBS cards are a feasible alternative for diagnosing and monitoring various diseases in the developing world. DBS sampling was also suitable to verify the presence of B-cell clonal populations circulating in the blood by immunoglobulin gene rearrangement analysis, with a view to offering molecular evaluation to the diagnosis and monitoring of lymphoproliferative diseases in resource-limited settings.

A diagnosis of leukemia is not usually problematic as immunophenotyping and cytogenetic analysis and histochemical staining can establish diagnosis in virtually all leukemia cases. However, a diagnosis of leukemia may sometimes be more complicated, and molecular clonality evaluation is thought to produce valuable additional information. DBS cards may be useful tools when the molecular analyses complementary to histomorphological/immunophenotypic evaluation are not available. The study was published in the October 2013 issue of the journal Leukemia Research.

Related Links:
University of Padua
Roche Applied Science
Invivoscribe Technologies



Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
Serological Pipet Controller
PIPETBOY GENIUS
New
Gold Member
Serological Pipets
INTEGRA Serological Pipets
New
Autoimmune Disease Diagnostic
Chorus ds-DNA-G
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Molecular Diagnostics

view channel
Image: The new RABTA sets a high standard in laboratory diagnostics (Photo courtesy of Randox)

Pioneering Analyzer with Advanced Biochip Technology Sets New Standard in Lab Diagnostics

A state-of-the-art analyzer combines advanced technology with exceptional efficiency to meet the demanding needs of modern laboratories. Randox Toxicology (Antrim, Ireland) has launched its pioneering... Read more

Immunology

view channel
Image: How the predictive test works (Photo courtesy of QMUL)

World’s First Clinical Test Predicts Best Rheumatoid Arthritis Treatment

Rheumatoid arthritis (RA) is a chronic condition affecting 1 in 100 people in the UK today, causing the immune system to attack its joints. Unlike osteoarthritis, which is caused by wear and tear, RA can... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.